Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study
Standard
Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study. / Muehlensiepen, Felix; Knitza, Johannes; Marquardt, Wenke; May, Susann; Krusche, Martin; Hueber, Axel; Schwarz, Julian; Vuillerme, Nicolas; Heinze, Martin; Welcker, Martin.
in: INT J ENV RES PUB HE, Jahrgang 18, Nr. 24, 13127, 13.12.2021.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study
AU - Muehlensiepen, Felix
AU - Knitza, Johannes
AU - Marquardt, Wenke
AU - May, Susann
AU - Krusche, Martin
AU - Hueber, Axel
AU - Schwarz, Julian
AU - Vuillerme, Nicolas
AU - Heinze, Martin
AU - Welcker, Martin
PY - 2021/12/13
Y1 - 2021/12/13
N2 - Despite all its promises, telemedicine is still not widely implemented in the care of rheumatic and musculoskeletal diseases (RMDs). The aim of this study is to investigate opportunities, barriers, acceptance, and preferences concerning telemedicine among RMD patients and professional stakeholders. From November 2017 to December 2019, a participatory, mixed-methods study was conducted, consisting of (1) expert interviews (n = 27) with RMD patients and professional stakeholders, (2) a national paper-based patient survey (n = 766), and (3) focus groups (n = 2) with patient representatives and rheumatologists. The qualitative findings indicate that patients equate personal contact with physical face-to-face contact, which could be reduced by implementing telemedicine, thus negatively influencing the patient-doctor relationship. Correspondingly "no personal contact with the doctor" is the main reason (64%) why 38% of the surveyed patients refuse to try telemedicine. Professional stakeholders expect telemedicine to contribute to the effective allocation of scarce resources in rheumatology care. The main barriers reported by stakeholders were the scarcity of time resources in RMD care, the absence of physical examinations, and organizational challenges associated with the implementation of telemedicine in RMD care. While the exact integration of telemedicine into routine care has yet to be found, the consequences on the patient-physician relationship must be permanently considered.
AB - Despite all its promises, telemedicine is still not widely implemented in the care of rheumatic and musculoskeletal diseases (RMDs). The aim of this study is to investigate opportunities, barriers, acceptance, and preferences concerning telemedicine among RMD patients and professional stakeholders. From November 2017 to December 2019, a participatory, mixed-methods study was conducted, consisting of (1) expert interviews (n = 27) with RMD patients and professional stakeholders, (2) a national paper-based patient survey (n = 766), and (3) focus groups (n = 2) with patient representatives and rheumatologists. The qualitative findings indicate that patients equate personal contact with physical face-to-face contact, which could be reduced by implementing telemedicine, thus negatively influencing the patient-doctor relationship. Correspondingly "no personal contact with the doctor" is the main reason (64%) why 38% of the surveyed patients refuse to try telemedicine. Professional stakeholders expect telemedicine to contribute to the effective allocation of scarce resources in rheumatology care. The main barriers reported by stakeholders were the scarcity of time resources in RMD care, the absence of physical examinations, and organizational challenges associated with the implementation of telemedicine in RMD care. While the exact integration of telemedicine into routine care has yet to be found, the consequences on the patient-physician relationship must be permanently considered.
KW - Focus Groups
KW - Humans
KW - Musculoskeletal Diseases
KW - Rheumatology
KW - Surveys and Questionnaires
KW - Telemedicine
U2 - 10.3390/ijerph182413127
DO - 10.3390/ijerph182413127
M3 - SCORING: Journal article
C2 - 34948737
VL - 18
JO - INT J ENV RES PUB HE
JF - INT J ENV RES PUB HE
SN - 1660-4601
IS - 24
M1 - 13127
ER -